Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yang Xia
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0000-0003-2487-2244
Observed ORCID:
0000-0003-2487-2244
OpenAlex ID:
A5123840390
EBUS-guided transbronchial mediastinal cryobiopsy for diagnosing non-metastatic lymphadenopathy: A randomized controlled trial
2026
·
Mingming Deng
, Ziwen Zheng
, et al.
·
Med
·
8
Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib
2026
·
Mo Zhou
, Yin Zhu
, et al.
·
npj Precision Oncology
·
2
PDF
International Consensus on Severe Lung Cancer—The Second Edition
2026
·
Xinqing Lin
, Qian Chu
, et al.
·
Translational Lung Cancer Research
·
1
A dynamic Host-Tumor Dual-Perspective Deep Learning Framework for Predicting Pathological Response to Neoadjuvant Chemoimmunotherapy in NSCLC
2026
·
Yang Xia
·
European Respiratory Journal
Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling
2026
·
Zhulin Liu
, Yin Zhu
, et al.
·
Lung Cancer
Mmda-01 Leptomeningeal Disease in Alk-positive Nsclc: Survival Impact of Third-generation Alk Inhibitors
2026
·
Kelsey Pan
, Meimei Zheng
, et al.
·
Neuro-Oncology Advances
Ultrasonic elastography-guided pleural biopsy followed by as-needed semi-rigid thoracoscopic pleural biopsy versus immediate semi-rigid thoracoscopic pleural biopsy for the diagnosis of pleural effusion (UPDATE-3): a protocol of randomised controlled trial
2026
·
Liwei Liao
, Jiangwei Ma
, et al.
·
Respiratory Research
Leptomeningeal disease in ALK-positive NSCLC: Survival impact of third-generation ALK inhibitors.
2026
·
Kelsey Pan
, Meimei Zheng
, et al.
·
Journal of Clinical Oncology
PDF
OA02.03: Molecular Diagnosis and Management of Leptomeningeal Metastases With Evolving Therapeutic Paradigm in Advanced Lung Cancer: A Contemporary Study
2026
·
Mei-Mei Zheng
, Li-Bo Tang
, et al.
·
Journal of Thoracic Oncology
Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies
2026
·
Yuxin Jiang
, Youzu Xu
, et al.
·
BMJ Oncology
PDF
Show more works
View as search
Works count:
10
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type